Described herein is an apparatus for evaluating biological cell cultures. The apparatus comprises a housing and a controller coupled to the housing over a data bus. The housing comprises a light source to generate light, a collimator to collimate the light generated by the light source, a linear stage to actuate a cell culture dish including a biological cell culture in orthogonal directions, and a photodetector to receive the collimated light through the cell culture dish and the biological cell culture. The controller is configured to provide instructions to operate the light source, the linear stage, and the photodetector over the data bus.
Described herein is an apparatus for evaluating biological cell cultures. The apparatus comprises a housing and a controller coupled to the housing over a data bus. The housing comprises a light source to generate light, a collimator to collimate the light generated by the light source, a linear stage to actuate a cell culture dish including a biological cell culture in orthogonal directions, and a photodetector to receive the collimated light through the cell culture dish and the biological cell culture. The controller is configured to provide instructions to operate the light source, the linear stage, and the photodetector over the data bus.
The present invention is directed to methods and compositions for the treatment of diverticulosis. It is more specifically directed to compositions including L-glutamine, its salts, or its derivatives, and uses of such compositions in the treatment of diverticulosis. In a method aspect, the present invention provides a method of treating diverticulosis. The method includes ingestion of 0.05 g/kg body weight to 10.0 g/kg body weight of L-glutamine, an L-glutamine salt or an L-glutamine derivative per day by a person who has diverticulosis.
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Pharmaceutical preparations for the treatment of
hematological conditions, diseases, and disorders, namely,
sickle cell disease; pharmaceutical preparations for the
treatment of gastrointestinal, metabolic, and diabetic
conditions, diseases, and disorders; nutraceuticals for use
as a dietary supplement.
5.
METHODS AND COMPOSITIONS FOR THE TREATMENT OF SICKLE CELL DISEASES AND THALASSEMIA
The present invention is generally directed to methods and compositions for the treatment of sickle cell diseases and thalassemia. It is more particularly directed to compositions containing L-glutamine, an L-glutamine salt or an L-glutamine derivative and at least one other active ingredient and methods using such compositions. In one aspect, the present invention is directed to a composition for treating sickle cell disease or β-thalassemia. The composition comprises: at least one gram of L-glutamine, an L-glutamine salt or an L-glutamine derivative; and, at least one gram of one type of fiber.
A61K 31/551 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep
A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
6.
Methods and compositions for the treatment of diverticulosis
The present invention is directed to methods and compositions for the treatment of diverticulosis. It is more specifically directed to compositions including L-glutamine, its salts, or its derivatives, and uses of such compositions in the treatment of diverticulosis. In a method aspect, the present invention provides a method of treating diverticulosis. The method includes ingestion of 0.05 g/kg body weight to 10.0 g/kg body weight of L-glutamine, an L-glutamine salt or an L-glutamine derivative per day by a person who has diverticulosis.
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Pharmaceuticals; Medical preparations; Pharmaceutical preparations for the treatment of hematological, gastrointestinal, metabolic, and diabetic conditions, diseases, and disorders; Sanitary preparations for medical purposes; Dietetic foods for medical use; Dietetic substances for medical use; Dietary supplements; nutraceuticals for use as a dietary supplement.
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Pharmaceuticals; Medical preparations; Pharmaceutical preparations for the treatment of hematological, gastrointestinal, metabolic, and diabetic conditions, diseases, and disorders; Sanitary preparations for medical purposes; Dietetic foods for medical use; Dietetic substances for medical use; Dietary supplements; nutraceuticals for use as a dietary supplement.
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Pharmaceuticals; Medical preparations; Pharmaceutical preparations for the treatment of hematological, gastrointestinal, metabolic, and diabetic conditions, diseases, and disorders; Sanitary preparations for medical purposes; Dietetic foods for medical use; Dietetic substances for medical use; Dietary supplements; nutraceuticals for use as a dietary supplement.
10.
Methods and compositions for the treatment of diverticulosis
The present invention is directed to methods and compositions for the treatment of diverticulosis. It is more specifically directed to compositions including L-glutamine, its salts, or its derivatives, and uses of such compositions in the treatment of diverticulosis. In a method aspect, the present invention provides a method of treating diverticulosis. The method includes ingestion of 0.05 g/kg body weight to 10.0 g/kg body weight of L-glutamine, an L-glutamine salt or an L-glutamine derivative per day by a person who has diverticulosis.
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Pharmaceutical preparations for the treatment of hematological conditions, diseases, and disorders, namely, sickle cell disease; pharmaceutical preparations for the treatment of gastrointestinal, metabolic, and diabetic conditions, diseases, and disorders; nutraceuticals for use as a dietary supplement
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Pharmaceutical preparations for the treatment of gastrointestinal and metabolic diseases and disorders; pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for use in hematology
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Pharmaceutical preparations for the treatment of gastrointestinal and metabolic diseases and disorders; pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for use in hematology
14.
Methods and compositions for the treatment of diverticulosis
The present invention is directed to methods and compositions for the treatment of diverticulosis. It is more specifically directed to compositions including L-glutamine, its salts, or its derivatives, and uses of such compositions in the treatment of diverticulosis. In a method aspect, the present invention provides a method of treating diverticulosis. The method includes ingestion of 0.05 g/kg body weight to 10.0 g/kg body weight of L-glutamine, an L-glutamine salt or an L-glutamine derivative per day by a person who has diverticulosis.
The present invention is directed to methods and compositions for the treatment of diverticulosis. It is more specifically directed to compositions including L-glutamine, its salts, or its derivatives, and uses of such compositions in the treatment of diverticulosis. In a method aspect, the present invention provides a method of treating diverticulosis. The method includes ingestion of 0.05 g/kg body weight to 10.0 g/kg body weight of L-glutarnine, an L-glutamine salt or an L-glutamine derivative per day by a person who has diverticulosis.
The present invention is directed to methods and compositions for the treatment of diabetes and related symptoms. It is more specifically directed to compositions including L-glutamine, its salts, or its derivatives, and uses of such compositions in the treatment of diabetes and related symptoms. In a method aspect, the present invention provides a method of treating diabetes. The method involves ingesting 0.05 g/kg body weight to 10.0 g/kg body weight of L-glutamine, an L-glutamine salt or an L-glutamine derivative per day by a person who has diabetes.
05 - Pharmaceutical, veterinary and sanitary products
42 - Scientific, technological and industrial services, research and design
Goods & Services
DIETARY AND NUTRITIONAL SUPPLEMENTS FOR GASTROINTESTINAL HEALTH AND FOR ENHANCING IMMUNE RESPONSE EXCLUDING ANIMAL FEED ADDITIVES AND PRODUCTS INTENDED FOR USE WITH ANIMALS [ PRODUCT RESEARCH AND DEVELOPMENT IN THE FIELDS OF DIETARY AND NUTRITIONAL SUPPLEMENTS AND PHARMACEUTICAL PREPARATIONS EXCLUDING SERVICES ASSOCIATED WITH ANIMAL FEED ADDITIVES AS WELL AS GOODS AND SERVICES INTENDED FOR USE IN ASSOCIATION WITH ANIMALS ]
